A new heavy internal tamponade in vitreoretinal surgery: An in vitro study

Eye

Volumn 22, Issue 8, 2008, Pages 1082-1088

  Tognetto, D ^a   Lepori, L ^b   Lapasin, R ^c   Minutola, D ^a   Sanguinetti, G ^a   Michelone, L ^a   Fanni, D ^a   Ravalico, G ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PERFLUOROHEXYLOCTANE; SILICONE OIL;

ARTICLE; CONTROLLED STUDY; DENSITOMETRY; EYE SURGERY; FLOW MEASUREMENT; IN VITRO STUDY; MISCIBILITY; RELATIVE DENSITY; SHEAR STRESS; SOLUBILITY; TEMPERATURE MEASUREMENT; TURBIDIMETRY; VISCOSITY; VITREORETINAL SURGERY;

EID: 50449085891     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.144     Document Type: Article

References (58)

1. McCuen III BW, de Juan Jr E, Machemer R. Silicone oil in vitreoretinal surgery. Part 1: Surgical techniques. Retina 1985; 5: 189-197.
2. McCuen II BW, de Juan Jr E, Landers III MB, Machemer R. Silicone oil in vitreoretinal surgery. Part 2: Results and complications. Retina 1985; 5: 198-205.
3. Sell CH, McCuen II BW, Landers III MB, Machemer R. Long-term results of successful vitrectomy with silicone oil for advanced proliferative vitreoretinopathy. Am J Ophthalmol 1987; 103: 24-28.
4. Hammer ME, Rinder DF, Hicks EL, Yang CH, Hornung CA. Tolerance of perfluorocarbons, fluorosilicone and silicone liquids in the vitreous. In: Freeman, Tolentino (eds). Proliferative Vitreoretinopathy. Springer-Verlag: New York, 1988, pp 156-161.
5. Sharma T, Gopal L, Shanmugam MP, Bhende PS, Agrawal R, Badrinath SS et al. Management of recurrent retinal detachment in silicone oil-filled eyes. Retina 2002; 22: 153-157.
6. Falkner CI, Binder S, Kruger A. Outcome after silicone oil removal. Br J Ophthalmol 2001; 85: 1324-1327.
7. Zilis JD, McCuen II BW, de Juan Jr E, Stefansson E, Machemer R. Results of silicone oil removal in advanced proliferative vitreoretinopathy. Am J Ophthalmol 1989; 108: 15-21.
8. Riedel KG, Gabel VP, Neubauer L, Kampik A, Lund OE. Intravitreal silicone oil injection: Complications and treatment of 415 consecutive patients. Graefes Arch Clin Exp Ophthalmol 1990; 228: 19-23.
9. Abrams GW, Azen SP, McCuen II BW, Flynn Jr HW, Lai MY, Ryan SJ. Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: Results of additional and long-term follow-up. Silicone Study report 11. Arch Ophthalmol 1997; 115 335-344.
10. Gabel VP, Kampik A, Gabel C, Spiegel D. Silicone oil with high specific gravity for intraocular use. Br J Ophthalmol 1987; 71: 262-267.
11. Nakamura K, Refojo MF, Crabtree DV, Pastor J, Leong FL. Ocular toxicity of low-molecular-weight components of silicone and fluorosilicone oils. Invest Ophthalmol Vis Sci 1991; 32: 3007-3020.
12. Friberg TR, Verstraeten TC, Wilcox DK. Effects of emulsification, purity, and fluorination of silicone oil on human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 1991; 32: 2030-2034.
13. Gremillion Jr CM, Peyman GA, Liu KR, Naguib KS. Fluorosilicone oil in the treatment of retinal detachment. Br J Ophthalmol 1990; 74 643-646.
14. Eckardt C, Schmidt D, Czank M. Intraocular tolerance to silicone oils of different specific gravities. An experimental study. Ophthalmologica 1990; 201: 133-139.
15. Peyman GA, Smith RT, Charles H. Injection of fluorosilicone oil and pars plana vitrectomy for complex retinal detachment. Can J Ophthalmol 1987; 22: 276-278.
16. De Molfetta V, Bottoni F, Arpa P, Vinciguerra P, Zenoni S. The effect of simultaneous internal tamponade on fluid compartmentalization and its relationship to cell proliferation. Retina 1992; 12: S40-S45.
17. Pastor JC, Lopez MI, Saornil MA, Refojo MF. Intravitreal silicone and fluorosilicone oils: Pathologic findings in rabbit eyes. Acta Ophthalmol 1992; 70: 651-658.
18. Chang S, Ozmert E, Zimmerman NJ. Intraoperative perfluorocarbon liquids in the management of proliferative vitreoretinopathy. Am J Ophthalmol 1988; 106: 668-674.
19. Verma LK, Peyman GA, Wafapoor H, Greve MD, Millsap CM, Adile SL. An analysis of posterior segment complications after vitrectomy using the perfluorocarbon perfluoroperhydrophenanthrene (Vitreon). Vitreon Collaborative Study. Ophthalmic Surg 1995; 26: 29-33.
20. Blinder KJ, Peyman GA, Desai UR, Nelson Jr NC, Alturki W, Paris CL. Vitreon, a short-term vitreoretinal tamponade. Br J Ophthalmol 1992; 76: 525-528.
21. Eckardt C, Nicolai U. Clinical and histologic findings after several weeks of intraocular tamponade with perfluorodecalin. Ophthalmologe 1993; 90: 443-447.
22. Eckardt C, Nicolai U, Winter M, Knop E. Experimental intraocular tolerance to liquid perfluorooctane and perfluoropolyether. Retina 1991; 11: 375-384.
23. Velikay M, Wedrich A, Stolba U, Datlinger P, Li Y, Binder S. Experimental long-term vitreous replacement with purified and nonpurified perfluorodecalin. Am J Ophthalmol 1993; 116: 565-570.
24. Langefeld S, Kirchhof B, Meinert H, Roy T, Aretz A, Schrage NF. A new way of removing silicone oil from the surface of silicone intraocular lenses. Graefes Arch Clin Exp Ophthalmol 1999; 23: 201-206.
25. Dick HB, Augustin AJ. Solvent for removing silicone oil from intraocular lenses: Experimental study comparing various biomaterials. J Cataract Refract Surg 2000; 26: 1667-1672.
26. Roider J, Hoerauf H, Kobuch K, Gabel VP. Clinical findings on the use of long-term heavy tamponades (semifluorinated alkanes and their oligomers) in complicated retinal detachment surgery. Graefes Arch Clin Exp Ophthalmol 2002; 240: 965-971.
27. Meinert H, Roy T. Semifluorinated alkanes-a new class of compounds with outstanding properties for use in ophthalmology. Eur J Ophthalmol 2000; 10: 189-197.
28. Kirchhof B, Wong D, Van Meurs J, Hilgers RD, Macek M, Lois N et al. Use of perfluorohexyloctane as a long-term internal tamponade agent in complicated retinal detachment surgery. Am J Ophthalmol 2002; 133: 95-101.
29. Hoerauf H, Kobuch K, Dresp J, Menz DH. Combined use of partially fluorinated alkanes, perfluorocarbon liquids and silicone oil: An experimental study. Graefes Arch Clin Exp Ophthalmol 2001; 239 373-381.
30. Herbert E, Stappler T, Wetterqvist C, Williams R, Wong D. Tamponade properties of double-filling with perfluorohexyloctane and silicone oil in a model eye chamber. Graefes Arch Clin Exp Ophthalmol 2003; 242: 250-254.
31. Novak JP, Matous J, Pick J. Liquid-Liquid Equilibria. Elsevier: Amsterdam, 1987.
32. Singh AK, Glaser BM, Lemor M, Michels RG. Gravity-dependent distribution of retinal pigment epithelial cells dispersed into the vitreous cavity. Retina 1986; 6: 77-80.
33. Chang S, Zimmerman NJ, Iwamoto T, Ortiz R, Faris D. Experimental vitreous replacement with perfluorotributylamine. Am J Ophthalmol 1987; 103: 29-37.
34. Peyman GA, Schulman JA, Sullivan B. Perfluorocarbon liquids in ophthalmology. Surv Ophthalmol 1995; 39: 375-395.
35. Chang S, Sparrow JR, Iwamoto T, Gershbein A, Ross R, Ortiz R. Experimental studies of tolerance to intravitreal perfluoro-n-octane liquid. Retina 1991; 11: 367-374.
36. Elsing SH, Fekrat S, Green WR, Chang S, Wajer SD, Haller JA. Clinicopathologic findings in eyes with retained perfluoro-n-octane liquid. Ophthalmology 2000; 108: 45-48.
37. Stefaniotou MI, Aspiotis MV, Kitsos GD, Kalogeropoulos CD, Asproudis IC, Psilas KG. Our experience with perfluorohexyloctane (F6H8) as a temporary endotamponade in vitreoretinal surgery. Eur J Ophthalmol 2002; 12: 518-522.
38. Wong D, Lois N. Perfluorocarbons and semifluorinated alkanes. Semin Ophthalmol 2000; 15: 25-35.
39. Kobuch K, Menz IH, Hoerauf H, Dresp JH, Gabel VP. New substances for intraocular tamponades: Perfluorocarbon liquids, hydrofluorocarbon liquids and hydrofluorocarbon-oligomers in vitreoretinal surgery. Graefes Arch Clin Exp Ophthalmol 2001; 239: 635-642.
40. Vote B, Wheen L, Cluroe A, Teoh H, McGeorge A. Further evidence for proinflammatory nature of perfluorohexyloctane in the eye. Clin Exp Ophthalmol 2003; 31: 408-414.
41. Mertens S, Bednarz J, Engelmann K. Evidence of toxic side effects of perfluorohexyloctane after vitreoretinal surgery as well as in previously established in vitro models with ocular cell types. Graefes Arch Clin Exp Ophthalmol 2002; 240: 989-995.
42. Malchiodi-Albedi F, Matteucci A, Formisano G, Paradisi S, Carnovale-Scalzo G, Perilli R et al. Perfluorohexyloctane (F6H8) induces structural modifications and increases apoptosis in rat primary retinal cultures. J Biomed Mater Res 2003; 15: 133-136.
43. Bottoni F, Arpa P, Vinciguerra P, Zenoni S, De Molfetta V. Combined silicone and fluorosilicone oil tamponade (double filling) in the management of complicated retinal detachment. Ophthalmologica 1992; 204: 77-81.
44. Peyman GA, Conway MD, Soike KF, Clark Jr LC. Long-term vitreous replacement in primates with intravitreal Vitreon or Vitreon plus silicone. Ophthalmic Surg 1991; 22: 657-664.
45. Williams R, Wong D. The influence of explants on the physical efficiency of tamponade agents. Graefes Arch Clin Exp Ophthalmol 1999; 237 870-874.
46. de Juan Jr E, McCuen B, Tiedeman J. Intraocular tamponade and surface tension. Surv Ophthalmol 1985; 30: 47-51.
47. Lepori L, Matteoli E, Spanedda A, Genovesi-Ebert F, Rizzo S. Combined use of perfluorohexyloctane and silicone oil as intraocular tamponade: an in vitro study. Graefes Arch Clin Exp Ophthalmol 2006; 244: 79-82.
48. Wetterqvist C, Wong D, Williams R, Stappler T, Herbert E, Freeburn S. Tamponade efficiency of perfluorohexyloctane and silicone oil solutions in a model eye chamber. Br J Ophthalmol 2004; 88: 692-696.
49. Wong D, Kumar I, Quah SA, Ali H, Valdeperas X, Romano MR. Comparison of postoperative intraocular pressure in patients with Densiron-68 vs conventional silicone oil: A case-control study. Eye advance online publication 7 December 2007; doi:10.1038/sj.eye.6703055.
50. Francis JH, Latkany PA, Rosenthal J. Mechanical energy from intraocular instruments cause emulsification of silicone oil. Br J Ophthalmol 2007; 91: 818-821.
51. Wickham LJ, Asaria RH, Alexander R, Luthert P, Charteris DG. Immunopathology of intraocular silicone oil: Retina and epiretinal membranes. Br J Ophthalmol 2007; 91: 258-262.
52. Heidenkummer HP, Kampik A, Theirfelder S. Emulsification of silicone oils with specific physiocochemical characteristics. Graefes Arch Clin Exp Ophthalmol 1991; 229: 88-94.
53. Bartov E, Pennarola F, Savion N, Naveh N, Treister G. A quantitative in-vitro model for silicone oil emulsification. Role of blood constituents. Retina 1992; 12: S23-S27.
54. Petersen J. The physical and surgical aspects of silicone oil in the vitreous cavity. Graefes Arch Clin Exp Ophthalmol 1987; 225: 452-456.
55. Dresp JH, Menz D-H. Interaction of different ocular endotamponades as a risk factor for silicone oil emulsification. Retina 2005; 25 902-910.
56. Knorr HL, Seltsam A, Holbach L, Naumann GO. Intraocular silicone oil tamponade. A clinico-pathologic study of 36 enucleated eyes. Ophthalmologe 1996; 93: 130-138.
57. Meinert H. Semifluorinated alkanes and their application. Eur. Patent no. 0003542, 1996.
58. Tognetto D, Minutola D, Sanguinetti G, Ravalico G. Anatomical and functional outcomes after heavy silicone oil tamponade in vitreoretinal surgery for complicated retinal detachment: A pilot study. Ophthalmology 2005; 112: 1574.